Rapport Therapeutics RAPP Institutional Ownership

NASDAQ RAPP

$45.77 -1.88 (-3.95%)

As of: Sep 4, 2026 · 3:59 PM EDT

Institutions by Trading Activity

161 Institutions

Increased 86 53.4%

Unchanged 28 17.4%

Reduced 47 29.2%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

108.48%

▼-2.65 pp QoQ

Shares Held by Institutions

51.50Mn

of 47.47Mn outstanding

▼-1.45% QoQ

Shares Outstanding

47.47Mn

-4.03Mn held outside 13F filers

Institutional Investors

161

filed 13F for Jun 2026

▲+14 vs prior quarter

Net Shares Added (QoQ)

-760.36K

distributed since last quarter

Value of Holdings

$2.45Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Rapport Therapeutics, Inc. (NASDAQ:RAPP) has 161 institutional investors that have filed 13F reports for the period ending June 2026.

They owned 108.5% of outstanding stock in June 2026, down from 111.1% the prior quarter.
They decreased total shares held in Rapport Therapeutics by -1.45% from last quarter, and the number of investors in RAPP increased 98.77% annually.
Of these 161 funds, 86 grew their exposure to Rapport Therapeutics, 47 cut back, and 28 maintained positions.
Combined, these investors held 51.5Mn shares in RAPP for June 2026, down by 760.36K shares quarter on quarter, and up 12.93Mn shares year over year.
As of June 30, 2026, FMR LLC held the largest stake in Rapport Therapeutics with 7.17Mn shares, accounting for 15.11% of total shares outstanding.
The largest buyers of Rapport Therapeutics for the quarter ending June 2026 were Sixth Street Partners Management Company, L.P. (246.82K), ALGERT GLOBAL LLC (223.82K), BlackRock, Inc. (193.83K), Candriam S.C.A. (161.72K), DIMENSIONAL FUND ADVISORS LP (137.62K).
The largest sales of RAPP for the quarter ending June 2026 came from TRV GP V, LLC (854.71K), Vestal Point Capital, LP (706.23K), Cormorant Asset Management, LP (300.0K), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (274.78K), T. Rowe Price Investment Management, Inc. (227.4K).
Per Business Quant data, the top 10 holders of Rapport Therapeutics for the quarter ending June 2026 are FMR LLC (7.17Mn), TRV GP V, LLC (6.28Mn), ARCH Venture Management, LLC (3.73Mn), Capital International Investors (2.92Mn), Goldman Sachs Group Inc (2.91Mn), BlackRock, Inc. (2.7Mn), Cormorant Asset Management, LP (2.66Mn), Sofinnova Investments, Inc. (1.9Mn), Johnson & Johnson (1.78Mn), Polar Capital Holdings Plc (1.61Mn).

Form 13F Holdings

161 Institutional Holders

Report period 30 Jun, 2026

Total shares held 51.50Mn

Of outstanding 108.48%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	FMR LLC	0000315066	7,172,894	15.11%	▲3,955	+0.06%	$298.89Mn
2	TRV GP V, LLC	0001990717	6,280,525	13.23%	▼854,708	-11.98%	$261.71Mn
3	ARCH Venture Management, LLC	0001274403	3,728,738	7.85%	0	0.00%	$155.38Mn
4	Capital International Investors	0001562230	2,921,958	6.15%	▼176,015	-5.68%	$121.76Mn
5	Goldman Sachs Group Inc	0000886982	2,910,449	6.13%	▼31,802	-1.08%	$121.28Mn
6	BlackRock, Inc.	0002012383	2,699,786	5.69%	▲193,831	+7.73%	$112.50Mn
7	Cormorant Asset Management, LP	0001583977	2,657,521	5.60%	▼300,000	-10.14%	$110.74Mn
8	Sofinnova Investments, Inc.	0001631134	1,904,408	4.01%	0	0.00%	$79.36Mn
9	Johnson & Johnson	0000200406	1,784,517	3.76%	0	0.00%	$74.36Mn
10	Polar Capital Holdings Plc	0001837309	1,608,514	3.39%	▼33,947	-2.07%	$67.03Mn
11	BAKER BROS. ADVISORS LP	0001263508	1,547,090	3.26%	0	0.00%	$64.47Mn
12	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	1,346,512	2.84%	▲21,430	+1.62%	$56.11Mn
13	TRV GP VI, LLC	0001990716	969,218	2.04%	0	0.00%	$40.39Mn
14	State Street Corp	0000093751	818,712	1.72%	▲59,160	+7.79%	$34.12Mn
15	GEODE CAPITAL MANAGEMENT, LLC	0001214717	793,453	1.67%	▲71,831	+9.95%	$33.07Mn
16	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	787,446	1.66%	▼79,010	-9.12%	$32.81K
17	PERCEPTIVE ADVISORS LLC	0001224962	773,342	1.63%	▲99,419	+14.75%	$32.23Mn
18	Vestal Point Capital, LP	0001974915	730,000	1.54%	▼706,229	-49.17%	$30.42Mn
19	ALLIANCEBERNSTEIN L.P.	0001109448	693,384	1.46%	▼34,459	-4.73%	$21.70Mn
20	UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	0000861177	644,082	1.36%	▼274,784	-29.90%	$26.84Mn

Showing 1 to 20 of 161 holders